Biote Maintains 2026 Revenue Guidance Above $190M After Q1 Voluntary Recall

Biote (BTMD) reported its Q1 2026 earnings on Wednesday, disclosing that a voluntary pellet recall during the quarter reduced both revenue and margins. The voluntary pellet recall occurred in Q1 2026 and negatively impacted Biote's Q1 2026 revenue. The same action also negatively impacted Biote's Q1 2026 margins, according to details shared on the earnings call.

Despite those effects, Biote maintained guidance for full-year 2026 revenue above $190 million. The company offered no revised outlook or additional quantitative details on the recall's dollar impact. com reported that the earnings call recap framed the recall as a temporary drag while the company held to its previously issued annual target.

No further breakdown of quarterly results or offsetting operational gains appeared in the disclosed information. The voluntary pellet recall represented the chief variable cited for the period's performance shortfalls. Biote did not disclose the precise timing of the recall within Q1 2026 or the specific pellet product involved.